Clinical Trial Update: A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating linaclotide's effect on abdominal girth in IBS-C; study terminated with results posted earlier.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• Linaclotide (linaclotide)

Snippet

Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Irritable Bowel Syndrome Characterized by Constipation | Phase 4 | Status: TERMINATED | Results posted: 2021-12-06